IP Library Granted Patent US 8,871,949
Granted Patent B2
US 8,871,949 · App. 12/757,622 · Granted Oct 28, 2014

Method for preparing FMOC-based hydrolysable linkers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,949
App. No.
12/757,622
Granted
Oct 28, 2014
Kind
B2
Abstract

A novel process for the production of Fmoc (9H-fluoren-9-ylmethoxycarbonyl)-based compounds is provided, wherein a protecting group for the 9-hydroxymethyl group of the fluorene ring system is utilized. These compounds are useful for the modification of protein and peptide drugs.

Claims (43)

1. A compound of the formula 1,

wherein PG is a silyl protecting group;

at least one of position 1, 2, 3, 4, 5, 6, 7 or 8 is bound to radical Y; and

at least one of an available position 1, 2, 3, 4, 5, 6, 7 or 8 is bound to radical X;

Y is

R 1 is independently a (C 1 -C 8 )-alkyl;

R 2 is selected from the group consisting of —C(O)NR—, —C(O)NR—(C 1 -C 8 )-alkyl-NR—, —NRC(O)— and —NRC(O)—(C 1 -C 8 )-alkyl-NR, and

R is independently hydrogen or C 1 -C 8 -alkyl;

X is —SO 3 —R 3 ;

R 3 is independently selected from the group consisting of hydrogen, (C 1 -C 8 )-alkyl and (C 1 -C 8 )-alkyl-R 4 ; and

R 4 is a polymer.

2. A method of preparing a compound according to formula 1:

wherein PG is a silyl protecting group and at least one of position 1, 2, 3, 4, 5, 6, 7 or 8 is bound to radical Y;

Y is

R 1 is independently a (C 1 -C 8 )-alkyl, and

R 2 is selected from the group consisting of —C(O)NR—, —C(O)NR—, —(C 1 -C 8 )-alkyl-NR—, —NRC(O)— and —NRC(O)—(C 1 -C 8 )-alkyl-NR, and

R is independently hydrogen or C 1 -C 8 -alkyl; and

at least one of an available position 1, 2, 3, 4, 5, 6, 7 or 8 is bound to radical X;

X is —SO 3 —R 3 ;

R 3 is independently selected from the group consisting of hydrogen, (C 1 -C 8 )-alkyl and (C 1 -C 8 )-alkyl-R 4 ; and

R 4 is a polymer;

said method comprises the step of reacting the 9-hydroxymethyl group of a compound of formula 2 to introduce PG:

wherein at least one of position 1, 2, 3, 4, 5, 6, 7, or 8 is bound to an amine,

and subsequently reacting the amine to introduce Y and form the compound of formula (1).

3. The method according to claim 2 , wherein said 9-hydroxymethyl group is reacted with a silyl halide.

4. The method according to claim 3 , wherein said silyl halide is tert-butyldimethylsilyl chloride (t-BDMS-Cl).

5. The method according to claim 4 , wherein said reaction with tBDMS-Cl is performed with imidazole in dimethylformamide.

6. The method according to claim 5 , wherein said amine is reacted with maleimidoalkylic acid.

7. The method according to claim 2 , wherein PG is tert-butyldimethylsilyl.

8. A method of preparing a compound according to formula 1:

wherein PG is a silyl protecting group;

at least one of position 1, 2, 3, 4, 5, 6, 7 or 8 is bound to radical Y;

Y is:

R 1 is a (C 1 -C 8 )-alkyl;

R 2 is selected from the group consisting of —NRC(O)— and —NRC(O)—(C 1 -C 8 )-alkyl-NR—,

R is hydrogen or C 1 -C 8 -alkyl;

at least one of an available position 1, 2, 3, 4, 5, 6, 7 or 8 is optionally bound to radical X;

X is —SO 3 —R 3 ;

R 3 is selected from the group consisting of hydrogen, (C 1 -C 8 )-alkyl and (C 1 -C 8 )-alkyl-R 4 ; and

R 4 is a polymer;

said method comprising protecting a hydroxyl of a compound of formula (2) with a silyl protecting group to form an intermediate compound:

wherein at least one of position 1, 2, 3, 4, 5, 6, 7, or 8 of formula (2) is bound to an amine, and reacting the amine of the intermediate compound to provide radical Y and form the compound of formula (1).

9. The method of claim 8 , wherein at least one of an available position 1, 2, 3, 4, 5, 6, 7 or 8 is bound to radical X.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2021
From: BAXALTA GMBH; BAXALTA INCORPORATED
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055189/0005 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER HEALTHCARE SA
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036362/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INTERNATIONAL INC.
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036374/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2010
From: TURECEK, PETER; SIEKMANN, JUERGEN; NOE, CHRISTIAN; STOIBER, GERHARD
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 024228/0204 →